X4 PHARMACEUTICALS, INC (XFOR) ROI
- 2023-12-31: ROI -95.74%.
- 2023-09-30: ROI -90.66%.
- 2023-06-30: ROI -129.39%.
- 2023-03-31: ROI -113.21%.
Complete source-backed roi history.
- Available history
- 2018-12-31 to 2023-12-31
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2023-12-31 | -95.74% |
| 2023-09-30 | -90.66% |
| 2023-06-30 | -129.39% |
| 2023-03-31 | -113.21% |
| 2022-12-31 | -87.18% |
| 2022-09-30 | -87.15% |
| 2022-06-30 | -131.44% |
| 2022-03-31 | -107.42% |
| 2021-12-31 | -90.19% |
| 2021-09-30 | -75.48% |
| 2020-12-31 | -58.63% |
| 2019-12-31 | -35.39% |
| 2019-09-30 | -53.73% |
| 2019-06-30 | -36.03% |
| 2019-03-31 | -75.11% |
| 2018-12-31 | 49.62% |
Annual ROI
| Date | ROI |
|---|---|
| 2023-12-31 | -95.74% |
| 2022-12-31 | -87.18% |
| 2021-12-31 | -90.19% |
| 2020-12-31 | -58.63% |
| 2019-12-31 | -35.39% |
| 2018-12-31 | 49.62% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |